プレガバリン (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "プレガバリン" in Japanese language version.

refsWebsite

Global rank Japanese rank

4^th place

24^th place

2^nd place

6^th place

222^nd place

498^th place

low place

low place

1nikkeibp.co.jp

1,415^th place

95^th place

low place

2,290^th place

6,690^th place

394^th place

361^st place

28^th place

195^th place

376^th place

1legeforeningen.no

low place

low place

doi.org

Schifano, Fabrizio; Orsolini, Laura; Duccio Papanti, G.; Corkery, John M. (2015). “Novel psychoactive substances of interest for psychiatry”. World Psychiatry 14 (1): 15–26. doi:10.1002/wps.20174. PMC 4329884. PMID 25655145.
Ohta, Hiroyoshi; Oka, Hiroshi; Usui, Chie; Ohkura, Masayuki; Suzuki, Makoto; Nishioka, Kusuki (2012). “A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia”. Arthritis Res. Ther. 14 (5): R217. doi:10.1186/ar4056. PMC 3580529. PMID 23062189.
Olesen, Søren Schou; Bouwense, Stefan A.W.; Wilder–Smith, Oliver H.G.; van Goor, Harry; Drewes, Asbjørn Mohr (2011). “Pregabalin Reduces Pain in Patients With Chronic Pancreatitis in a Randomized, Controlled Trial”. Gastroenterology 141 (2): 536–543. doi:10.1053/j.gastro.2011.04.003. PMID 21683078.
Yosipovitch, Gil; Bernhard, Jeffrey D. (2013). “Chronic Pruritus”. N. Eng. J. Med. 368 (17): 1625–1634. doi:10.1056/NEJMcp1208814. PMID 23614588.
Allen, Richard P.; Chen, Crystal; Garcia-Borreguero, Diego; Polo, Olli; DuBrava, Sarah; Miceli, Jeffrey; Knapp, Lloyd; Winkelman, John W. (2014). “Comparison of Pregabalin with Pramipexole for Restless Legs Syndrome”. N. Eng. J. Med. 370 (7): 621–631. doi:10.1056/NEJMoa1303646. PMID 24521108.
Schjerning, Ole; Rosenzweig, Mary; Pottegård, Anton; Damkier, Per; Nielsen, Jimmi (2016). “Abuse Potential of Pregabalin”. CNS Drugs 30 (1): 9–25. doi:10.1007/s40263-015-0303-6. PMID 26767525.

jcqhc.or.jp

minds.jcqhc.or.jp

繊維筋痛症治療ガイドライン2013 日本線維筋痛症学会編 (PDF)

legeforeningen.no

“Gabapentin and pregabalin: abuse and addiction” (pdf). Prescrire Int (128): 152–4. (2012). PMID 22822593.

nih.gov

pubmed.ncbi.nlm.nih.gov

Schifano, Fabrizio; Orsolini, Laura; Duccio Papanti, G.; Corkery, John M. (2015). “Novel psychoactive substances of interest for psychiatry”. World Psychiatry 14 (1): 15–26. doi:10.1002/wps.20174. PMC 4329884. PMID 25655145.
Ohta, Hiroyoshi; Oka, Hiroshi; Usui, Chie; Ohkura, Masayuki; Suzuki, Makoto; Nishioka, Kusuki (2012). “A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia”. Arthritis Res. Ther. 14 (5): R217. doi:10.1186/ar4056. PMC 3580529. PMID 23062189.
Olesen, Søren Schou; Bouwense, Stefan A.W.; Wilder–Smith, Oliver H.G.; van Goor, Harry; Drewes, Asbjørn Mohr (2011). “Pregabalin Reduces Pain in Patients With Chronic Pancreatitis in a Randomized, Controlled Trial”. Gastroenterology 141 (2): 536–543. doi:10.1053/j.gastro.2011.04.003. PMID 21683078.
Yosipovitch, Gil; Bernhard, Jeffrey D. (2013). “Chronic Pruritus”. N. Eng. J. Med. 368 (17): 1625–1634. doi:10.1056/NEJMcp1208814. PMID 23614588.
Allen, Richard P.; Chen, Crystal; Garcia-Borreguero, Diego; Polo, Olli; DuBrava, Sarah; Miceli, Jeffrey; Knapp, Lloyd; Winkelman, John W. (2014). “Comparison of Pregabalin with Pramipexole for Restless Legs Syndrome”. N. Eng. J. Med. 370 (7): 621–631. doi:10.1056/NEJMoa1303646. PMID 24521108.
“Gabapentin and pregabalin: abuse and addiction” (pdf). Prescrire Int (128): 152–4. (2012). PMID 22822593.
Schjerning, Ole; Rosenzweig, Mary; Pottegård, Anton; Damkier, Per; Nielsen, Jimmi (2016). “Abuse Potential of Pregabalin”. CNS Drugs 30 (1): 9–25. doi:10.1007/s40263-015-0303-6. PMID 26767525.

pmc.ncbi.nlm.nih.gov

Schifano, Fabrizio; Orsolini, Laura; Duccio Papanti, G.; Corkery, John M. (2015). “Novel psychoactive substances of interest for psychiatry”. World Psychiatry 14 (1): 15–26. doi:10.1002/wps.20174. PMC 4329884. PMID 25655145.
Ohta, Hiroyoshi; Oka, Hiroshi; Usui, Chie; Ohkura, Masayuki; Suzuki, Makoto; Nishioka, Kusuki (2012). “A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia”. Arthritis Res. Ther. 14 (5): R217. doi:10.1186/ar4056. PMC 3580529. PMID 23062189.

ncbi.nlm.nih.gov

Ohta, Hiroyoshi; Oka, Hiroshi; Usui, Chie; Ohkura, Masayuki; Suzuki, Makoto; Nishioka, Kusuki (2012). “A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia”. Arthritis Res. Ther. 14 (5): R217. doi:10.1186/ar4056. PMC 3580529. PMID 23062189.

nikkeibp.co.jp

medical.nikkeibp.co.jp

“米国でVioxxの服用による急性心筋梗塞や心臓突然死は５年間で約２万7000イベント”. 日経メディカル. (2004年11月6日) 2019年11月12日閲覧。

pmda.go.jp

info.pmda.go.jp

"添付文書 - リリカカプセル25mg／リリカカプセル75mg／リリカカプセル150mg／リリカOD錠25mg／リリカOD錠75mg／リリカOD錠150mg"

who.int

World Health Organization (6 December 2017). PREGABALIN Pre-Review Report Agenda Item 5.1 : Expert Committee on Drug Dependence Thirty-ninth Meeting (pdf) (Report). 世界保健機関. 2017年12月5日閲覧。

wiley.com

onlinelibrary.wiley.com

Schifano, Fabrizio; Orsolini, Laura; Duccio Papanti, G.; Corkery, John M. (2015). “Novel psychoactive substances of interest for psychiatry”. World Psychiatry 14 (1): 15–26. doi:10.1002/wps.20174. PMC 4329884. PMID 25655145.

yakugai.gr.jp

“心血管リスクのため主力製品・COX-2阻害薬の販売をメルク社が中止”. 薬害オンブズパーソン会議 (2004年10月21日). 2019年11月12日閲覧。

yomiuri.co.jp

“神経障害性の痛み治療薬「リリカ」に重い副作用” (2014年9月17日). 2014年9月18日閲覧。